Acceler8 Ventures revealed on Tuesday that chairman Nigel Rudd had acquired 121,429 ordinary shares in the London-listed life sciences business.
Acceler8 Ventures
20 October 2026 15:33:01
Source: Sharecast
Rudd, who joined Accler8 in August 2023, purchased the shares at an average price of 70p each, for a total price of £85,000.30.
Following the transaction, Rudd holds a beneficial interest in 10.64m ordinary Acceler8 shares, representing approximately 1.40% of the company's issued ordinary share capital.
As of 1530 BST, Acceler8 shares were up 4.84% at 65p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
The Character Group (CCT) Director name: Shah,Kirankumar Premshand Amount purchased: 67,611 @ 310.00p Value: £209,594.09
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
